{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:46Z","timestamp":1790892646894,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>We sought to evaluate racial disparities in disease outcomes among children with polyarticular juvenile idiopathic arthritis (JIA) during a treat-to-target (TTT) intervention with clinical decision support (CDS).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a retrospective analysis of a TTT-CDS strategy integrated into clinical practice for children with polyarticular JIA at a single center from 2016 to 2019. The primary outcome was the clinical Juvenile Arthritis Disease Activity Score (cJADAS-10). We used multivariable linear regression to assess racial differences in disease outcomes at the index visit (first visit after implementation). The effect of race on disease outcomes over time was estimated using linear mixed-effects models, stratified by incident or prevalent disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We included 159 children with polyarticular JIA, of which 74, 13 and 13% were white, black, and Asian\/other, respectively. cJADAS-10 improved significantly over time for all race categories, while the rates of improvement did not differ by race in incident (<jats:italic>p<\/jats:italic>\u2009=\u20090.53) or prevalent cases (<jats:italic>p<\/jats:italic>\u2009=\u20090.58). cJADAS-10 over time remained higher among black children compared to white children (\u03b2 2.5, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 and \u03b2 1.2, <jats:italic>p<\/jats:italic>\u2009=\u20090.08 for incident and prevalent cases, respectively). Provider attestation to CDS use at \u226550% of encounters was associated with a 3.9 greater reduction in cJADAS-10 among black children compared to white children (<jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Despite similar rates of improvement over time by race, disparities in JIA outcomes persisted throughout implementation of a TTT-CDS approach. More consistent CDS use may have a greater benefit among black children and needs to be explored further.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12969-020-00485-y","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T13:03:24Z","timestamp":1605272604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-4814","authenticated-orcid":false,"given":"Joyce C.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela F.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"11","key":"485_CR1","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.21389","volume":"52","author":"CA Wallace","year":"2005","unstructured":"Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(11):3554\u201362.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"485_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/acr.22259","volume":"66","author":"S Ringold","year":"2014","unstructured":"Ringold S, Weiss PF, Colbert RA, DeWitt EM, Lee T, Onel K, et al. Childhood arthritis and rheumatology research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res. 2014;66(7):1063\u201372.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"485_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3899\/jrheum.121147","volume":"40","author":"S Ringold","year":"2013","unstructured":"Ringold S, Beukelman T, Nigrovic PA, Kimura Y. CARRA registry site principal investigators, Birmingham J, et al. race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the childhood arthritis and rheumatology research Alliance (CARRA) registry. J Rheumatol. 2013;40(6):936\u201342.","journal-title":"J Rheumatol"},{"issue":"7","key":"485_CR4","first-page":"1475","volume":"34","author":"B Bruce","year":"2007","unstructured":"Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007;34(7):1475\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"485_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/RHU.0000000000000472","volume":"23","author":"GS Kerr","year":"2017","unstructured":"Kerr GS, Swearingen C, Mikuls TR, Yazici Y. Use of biologic therapy in racial minorities with rheumatoid arthritis from 2 US health care systems: JCR. J Clin Rheumatol. 2017;23(1):12\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"485_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/acr.21798","volume":"65","author":"L-H Chu","year":"2013","unstructured":"Chu L-H, Portugal C, Kawatkar AA, Stohl W, Nichol MB. Racial\/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res. 2013;65(2):299\u2013303.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"485_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jama.2011.67","volume":"305","author":"G Schmajuk","year":"2011","unstructured":"Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, et al. Receipt of disease-modifying Antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA. 2011;305(5):480.","journal-title":"JAMA."},{"issue":"5","key":"485_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/acr.20040","volume":"62","author":"SL Bridges","year":"2010","unstructured":"Bridges SL, Causey ZL, Burgos PI, Huynh BQN, Hughes LB, Danila MI, et al. Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study. Arthritis Care Res. 2010;62(5):624\u201331.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"485_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11926-012-0276-0","volume":"14","author":"CA McBurney","year":"2012","unstructured":"McBurney CA, Vina ER. Racial and ethnic disparities in rheumatoid arthritis. Curr Rheumatol Rep. 2012;14(5):463\u201371.","journal-title":"Curr Rheumatol Rep"},{"issue":"5_suppl","key":"485_CR10","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1177\/1077558707305413","volume":"64","author":"MH Chin","year":"2007","unstructured":"Chin MH, Walters AE, Cook SC, Huang ES. Interventions to Reduce Racial and Ethnic Disparities in Health Care. Med Care Res Rev. 2007;64(5_suppl):7S\u201328S.","journal-title":"Med Care Res Rev"},{"issue":"9","key":"485_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1136\/ard.2004.030924","volume":"64","author":"J Fransen","year":"2005","unstructured":"Fransen J, Moens HB, Speyer I, van Riel PLCM. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis. 2005;64(9):1294\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"9430","key":"485_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet Lond Engl. 2004;364(9430):263\u20139.","journal-title":"Lancet Lond Engl"},{"key":"485_CR13","doi-asserted-by":"crossref","unstructured":"Klein A, Minden K, Hospach A, Foeldvari I, Weller-Heinemann F, Trauzeddel R, et al. Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis. Ann Rheum Dis. 2020.","DOI":"10.1136\/annrheumdis-2019-216843"},{"issue":"1","key":"485_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/annrheumdis-2018-213902","volume":"78","author":"P Hissink Muller","year":"2019","unstructured":"Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, et al. Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial. Ann Rheum Dis. 2019;78(1):51\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"485_CR15","first-page":"819","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77(6):819\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"485_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12969-020-00428-7","volume":"18","author":"CG Schoemaker","year":"2020","unstructured":"Schoemaker CG, Swart JF, Wulffraat NM. Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals? Pediatr Rheumatol Online J. 2020;18(1):34.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"485_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3899\/jrheum.190268","volume":"47","author":"L Buckley","year":"2020","unstructured":"Buckley L, Ware E, Kreher G, Wiater L, Mehta J, Burnham JM. Outcome monitoring and clinical decision support in Polyarticular juvenile idiopathic arthritis. J Rheumatol. 2020;47(2):273\u201381.","journal-title":"J Rheumatol"},{"issue":"1","key":"485_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"485_CR19","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"F Mcerlane","year":"2013","unstructured":"Mcerlane F, Beresford MW, Baildam EM, Chieng SEA, Davidson JE, Foster HE, et al. Validity of a three-variable juvenile arthritis disease activity score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013;72(12):1983\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"485_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jclinepi.2010.10.012","volume":"64","author":"EM DeWitt","year":"2011","unstructured":"DeWitt EM, Stucky BD, Thissen D, Irwin DE, Langer M, Varni JW, et al. Construction of the eight-item patient-reported outcomes measurement information system pediatric physical function scales: built using item response theory. J Clin Epidemiol. 2011;64(7):794\u2013804.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"485_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/acr.22937","volume":"69","author":"TG Brandon","year":"2017","unstructured":"Brandon TG, Becker BD, Bevans KB, Weiss PF. Patient-reported outcomes measurement information system tools for collecting patient-reported outcomes in children with juvenile arthritis: validity of PROMIS tools for juvenile arthritis. Arthritis Care Res. 2017;69(3):393\u2013402.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"485_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/acr.22393","volume":"66","author":"A Consolaro","year":"2014","unstructured":"Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, et al. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score: cutoffs of the three-variable JADAS. Arthritis Care Res. 2014;66(11):1703\u20139.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"485_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.amjmed.2013.09.002","volume":"126","author":"JD Greenberg","year":"2013","unstructured":"Greenberg JD, Spruill TM, Shan Y, Reed G, Kremer JM, Potter J, et al. Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. Am J Med. 2013;126(12):1089\u201398.","journal-title":"Am J Med"},{"issue":"9","key":"485_CR24","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/acr.20525","volume":"63","author":"JL Barton","year":"2011","unstructured":"Barton JL, Trupin L, Schillinger D, Gansky SA, Tonner C, Margaretten M, et al. Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res. 2011;63(9):1238\u201346.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"485_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/acr.23709","volume":"71","author":"K Minden","year":"2019","unstructured":"Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, et al. Time of disease-modifying Antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a drug-free remission in young adulthood. Arthritis Care Res. 2019;71(4):471\u201381.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"485_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MLR.0b013e31818af829","volume":"47","author":"F Constantinescu","year":"2009","unstructured":"Constantinescu F, Goucher S, Weinstein A, Fraenkel L. Racial disparities in treatment preferences for rheumatoid arthritis. Med Care. 2009;47(3):350\u20135.","journal-title":"Med Care"},{"issue":"4","key":"485_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/art.24338","volume":"61","author":"F Constantinescu","year":"2009","unstructured":"Constantinescu F, Goucher S, Weinstein A, Smith W, Fraenkel L. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum. 2009;61(4):413\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"485_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/art.24457","volume":"61","author":"JL Barton","year":"2009","unstructured":"Barton JL. The role of race in patient preferences for treatment in rheumatoid arthritis. Arthritis Rheum. 2009;61(4):411\u20132.","journal-title":"Arthritis Rheum"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-020-00485-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T13:14:28Z","timestamp":1605273268000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00485-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An exemption and waiver of consent was approved for this study by the Children\u2019s Hospital of Philadelphia Institutional Review Board (#18\u2013014808) for the conduct of secondary research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.C. and J.B. report grant funding from GlaxoSmithKline for research outside of this work. The remaining listed authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}